Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL

Conditions: Angioimmunoblastic T-cell Lymphoma Interventions: Drug: mitoxantrone liposome 16 and azacitidine; Drug: mitoxantrone liposome 18 and azacitidine; Drug: mitoxantrone liposome 20 and azacitidine Sponsors: Huijing Wu; Beijing Xisike Clinical Oncology Research Foundation; CSPC Pharmaceutical Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials